-
Semgo 7mg (Semaglutide) is an FDA-approved oral medication designed to manage Type 2 Diabetes Mellitus (T2DM) promote effective weight loss and reduce the risk of chronic kidney disease and cardiovascular events. Convenient and effective it is part of the only Semaglutide pill approved since September 2019 for adult patients. -
Semgo 14mg (Semaglutide) is an FDA approved oral medication used to manage Type 2 Diabetes Mellitus (T2DM) promote weight loss and reduce the risk of chronic kidney disease and major cardiovascular events. Available in 3mg 7mg and 14mg doses Semgo 14mg is effective in long term blood sugar control and overall health improvement. -
Semgo Injection (Semaglutide) is an effective, once-weekly subcutaneous injection used to manage Type 2 Diabetes Mellitus (T2DM), promote sustainable weight loss, and reduce the risk of chronic kidney disease and major cardiovascular events. Available in progressive 0.25mg, 0.5mg, and 1mg pre-filled syringe doses, Semgo Injection mimics natural metabolic hormones to safely regulate long-term blood sugar, suppress appetite, and support overall cardio-renal and liver health.






